Scarica l'app Stockscreener
12.79
4.31%
0.49
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Borsa (PILL) Ultime notizie
Wheat Closes with Mixed Action on Tuesday - Barchart.com
The Standard YouTube Channel Surpasses 100,000 Subscribers - Barchart.com
Global Peer Financing Association (GPFA) ferme les marchés - Barchart.com
Shootin' the Bull about who gets to put on the pounds - Barchart.com
Qualcomm Is Teaming Up With ByteDance. What It Means for QCOM Stock - Barchart.com
Datadog Benefits When AI Goes Into Production. Here’s Why You Should Buy DDOG Stock Now. - Barchart.com
Grain Spreads: Impressive Demand Remains in Corn - Barchart.com
How major US stock indexes fared Tuesday 5/26/2026 - Barchart.com
PBF Energy Announces Pricing of $500 Million of Senior Notes due 2034 - Barchart.com
Semtech’s (NASDAQ:SMTC) Q1 Sales Top Estimates, Stock Soars - Barchart.com
Pharma Underperformed for Years. The Past 12 Months Tell a Different Story. Trade the Momentum With 3X Leverage. - Barchart.com
Congressional Black Caucus presses companies in the US to oppose Republican redistricting push - Barchart.com
Pangaea, Covenant Logistics, and Landstar Shares Skyrocket, What You Need To Know - Barchart.com
Royal Caribbean and Viking Shares Are Soaring, What You Need To Know - Barchart.com
Why Novavax (NVAX) Stock Is Trading Up Today - Barchart.com
AppLovin (APP) Stock Trades Up, Here Is Why - Barchart.com
Is Wall Street Bullish or Bearish on West Pharmaceutical Services Stock? - Barchart.com
Are Wall Street Analysts Predicting STERIS Stock Will Climb or Sink? - Barchart.com
Beth Lowry named to Georgia Power Board of Directors - Barchart.com
(PILL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Are Wall Street Analysts Predicting Jacobs Solutions’ Stock Will Climb or Sink? - Barchart.com
Rising Rates Are Threatening to Kill the Zombies and Send Small-Cap Stocks Plunging - Barchart.com
What Are Wall Street Analysts' Target Price for VeriSign Stock? - Barchart.com
Revvity Stock: Analyst Estimates & Ratings - Barchart.com
Do Wall Street Analysts Like Ares Management Stock? - Barchart.com
Northern Trust Stock: Analyst Estimates & Ratings - Barchart.com
Are Wall Street Analysts Predicting Brown & Brown Stock Will Climb or Sink? - Barchart.com
Are Wall Street Analysts Predicting Republic Services Stock Will Climb or Sink? - Barchart.com
What Are Wall Street Analysts' Target Price for Leidos Holdings Stock? - Barchart.com
Dear Google Stock Fans, Mark Your Calendars for May 19 - Barchart.com
Is Wall Street Bullish or Bearish on Northrop Grumman Stock? - Barchart.com
Wheat Extending Gains as the Crop Deteriorates - Barchart.com
The $3 Trillion Battery Problem’s Bigger Than You Think. But Not For This Startup. - Barchart.com
HSBC Upgrades Cisco Systems (CSCO) to Buy, Hikes PT - Barchart.com
Liquidity Mapping Around (PILL) Price Events - Stock Traders Daily
Direxion Daily Pharmaceutical & Medical Bull 3x Etf Live Share Price (PILL.US) - London South East
FirstEnergy Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Is Wall Street Bullish or Bearish on Live Nation Stock? - Barchart.com
Why MasterCraft (MCFT) Stock Is Trading Up Today - Barchart.com
Why (PILL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Inverse and Leveraged ETFs: How Do They Work? - Britannica
Top Performing Leveraged/Inverse ETFs: 04/26/2026 - etftrends.com
Should You Buy X-Energy Stock After the Amazon-Backed XE IPO? - Barchart.com
LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout - 24/7 Wall St.
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0327 - MSN
ARCA Stocks: Research Stocks from ARCA - GuruFocus
Workday Earnings Preview: What to Expect - Barchart.com
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0109 - msn.com
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now - AOL.com
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now - 24/7 Wall St.
What to know about a federal order reclassifying medical marijuana as a less dangerous drug - Barchart.com
Understanding Momentum Shifts in (PILL) - Stock Traders Daily
Volatility Meets Earnings Season – Q1 2026 - Direxion
Should You Chase the Rally in SoundHound Stock Today? - Barchart.com
If Technology Stocks Are Ready To Rally, The Leveraged TECL ETF Will Magnify Gains - Seeking Alpha
JPMorgan Is Betting on the ‘American Dream’ with a New $1.5 Trillion Initiative. What Does That Really Mean? - Barchart.com
Avoiding Lag: Real-Time Signals in (PILL) Movement - Stock Traders Daily
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Microsoft's Q3 2026 Earnings: What to Expect - Barchart.com
Stock List: Research Stocks from Around the World - gurufocus.com
Discipline and Rules-Based Execution in PILL Response - Stock Traders Daily
Direxion Daily Healthcare Bull 3X Shares declares quarterly distribution of $0.2912 - MSN
What You Need To Know Ahead of Johnson & Johnson's Earnings Release - Barchart.com
Osteoarthritis Pipeline Witnesses Strong Expansion with 100+ Companies Advancing 110+ Innovative Therapies | DelveInsight - Barchart
Direxion Daily Healthcare Bull 3X Shares declares quarterly distribution of $0.3101 - MSN
Behavioral Patterns of PILL and Institutional Flows - Stock Traders Daily
Cattle Bouncing Ahead of Cattle on Feed Report - Barchart.com
$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com
Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis - Barchart
SOXL Semiconductor Bull 3X ETF: Watch Nothing But Price Action (Technical Analysis) - Seeking Alpha
Medical Biomimetics Market Forecast to Reach USD 85.94 Billion by 2031 Driven by Tissue Engineering Demand, Regenerative Medicine Adoption, and Expanding Clinical Applications - Barchart.com
How Is West Pharmaceutical's Stock Performance Compared to Other Healthcare Stocks? - Barchart
Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart.com
Should You Buy Coherent Stock Before It Joins the S&P 500 on March 23? - Barchart.com
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight | Kartos Therapeutics, AOP Orphan Pharmaceuticals - Barchart
0.73%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):